Drug
Cadonilimab Combined Albumin Paclitaxel
Cadonilimab Combined Albumin Paclitaxel: highest development phase Phase 2, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil NCT05947201 | Phase 2 | The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC |
Latest
No recent events.
Follow Cadonilimab Combined Albumin Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.